BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 14517837)

  • 21. Adiponectin stimulates Wnt inhibitory factor-1 expression through epigenetic regulations involving the transcription factor specificity protein 1.
    Liu J; Lam JB; Chow KH; Xu A; Lam KS; Moon RT; Wang Y
    Carcinogenesis; 2008 Nov; 29(11):2195-202. PubMed ID: 18701434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
    Benhaj K; Akcali KC; Ozturk M
    Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular retinoic acid-binding protein 2 is down-regulated in prostate cancer.
    Okuducu AF; Janzen V; Ko Y; Hahne JC; Lu H; Ma ZL; Albers P; Sahin A; Wellmann A; Scheinert P; Wernert N
    Int J Oncol; 2005 Nov; 27(5):1273-82. PubMed ID: 16211222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inverse correlation of secreted frizzled-related protein 4 and beta-catenin expression in endometrial stromal sarcomas.
    Hrzenjak A; Tippl M; Kremser ML; Strohmeier B; Guelly C; Neumeister D; Lax S; Moinfar F; Tabrizi AD; Isadi-Moud N; Zatloukal K; Denk H
    J Pathol; 2004 Sep; 204(1):19-27. PubMed ID: 15307134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WIF1, an inhibitor of the Wnt pathway, is rearranged in salivary gland tumors.
    Queimado L; Lopes CS; Reis AM
    Genes Chromosomes Cancer; 2007 Mar; 46(3):215-25. PubMed ID: 17171686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
    Dahl E; Wiesmann F; Woenckhaus M; Stoehr R; Wild PJ; Veeck J; Knüchel R; Klopocki E; Sauter G; Simon R; Wieland WF; Walter B; Denzinger S; Hartmann A; Hammerschmied CG
    Oncogene; 2007 Aug; 26(38):5680-91. PubMed ID: 17353908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and classification of differentially expressed genes in non-small cell lung cancer by expression profiling on a global human 59.620-element oligonucleotide array.
    Hofmann HS; Bartling B; Simm A; Murray R; Aziz N; Hansen G; Silber RE; Burdach S
    Oncol Rep; 2006 Sep; 16(3):587-95. PubMed ID: 16865260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Epigenetic inactivation of the WNT antagonist SFRP1 in breast cancer].
    Dahl E; Veeck J; An H; Wiesmann F; Klopocki E; Sauter G; Kristiansen G; Hartmann A; Knüchel R
    Verh Dtsch Ges Pathol; 2005; 89():169-77. PubMed ID: 18035687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down-regulation of PHLDA1 gene expression is associated with breast cancer progression.
    Nagai MA; Fregnani JH; Netto MM; Brentani MM; Soares FA
    Breast Cancer Res Treat; 2007 Nov; 106(1):49-56. PubMed ID: 17211533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.
    Woenckhaus M; Klein-Hitpass L; Grepmeier U; Merk J; Pfeifer M; Wild P; Bettstetter M; Wuensch P; Blaszyk H; Hartmann A; Hofstaedter F; Dietmaier W
    J Pathol; 2006 Oct; 210(2):192-204. PubMed ID: 16915569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced FEZ1/LZTS1 expression and outcome prediction in lung cancer.
    Nonaka D; Fabbri A; Roz L; Mariani L; Vecchione A; Moore GW; Tavecchio L; Croce CM; Sozzi G
    Cancer Res; 2005 Feb; 65(4):1207-12. PubMed ID: 15735004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling.
    Kawakami K; Enokida H; Tachiwada T; Gotanda T; Tsuneyoshi K; Kubo H; Nishiyama K; Takiguchi M; Nakagawa M; Seki N
    Oncol Rep; 2006 Sep; 16(3):521-31. PubMed ID: 16865252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thiamine transporter gene expression and exogenous thiamine modulate the expression of genes involved in drug and prostaglandin metabolism in breast cancer cells.
    Liu S; Stromberg A; Tai HH; Moscow JA
    Mol Cancer Res; 2004 Aug; 2(8):477-87. PubMed ID: 15328374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A quantitative reverse transcription and polymerase chain reaction assay for human IGF-II allows direct comparison of IGF-II mRNA levels in cancerous breast, bladder, and prostate tissues.
    Fichera E; Liang S; Xu Z; Guo N; Mineo R; Fujita-Yamaguchi Y
    Growth Horm IGF Res; 2000 Apr; 10(2):61-70. PubMed ID: 10931743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors.
    Klopocki E; Kristiansen G; Wild PJ; Klaman I; Castanos-Velez E; Singer G; Stöhr R; Simon R; Sauter G; Leibiger H; Essers L; Weber B; Hermann K; Rosenthal A; Hartmann A; Dahl E
    Int J Oncol; 2004 Sep; 25(3):641-9. PubMed ID: 15289865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution of the androgen receptor pathway during progression of prostate cancer.
    Hendriksen PJ; Dits NF; Kokame K; Veldhoven A; van Weerden WM; Bangma CH; Trapman J; Jenster G
    Cancer Res; 2006 May; 66(10):5012-20. PubMed ID: 16707422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The iroquois homeobox gene 5 is regulated by 1,25-dihydroxyvitamin D3 in human prostate cancer and regulates apoptosis and the cell cycle in LNCaP prostate cancer cells.
    Myrthue A; Rademacher BL; Pittsenbarger J; Kutyba-Brooks B; Gantner M; Qian DZ; Beer TM
    Clin Cancer Res; 2008 Jun; 14(11):3562-70. PubMed ID: 18519790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation.
    Veeck J; Chorovicer M; Naami A; Breuer E; Zafrakas M; Bektas N; Dürst M; Kristiansen G; Wild PJ; Hartmann A; Knuechel R; Dahl E
    Oncogene; 2008 Jan; 27(6):865-76. PubMed ID: 17653090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. X-radiation induces non-small-cell lung cancer apoptosis by upregulation of Axin expression.
    Han Y; Wang Y; Xu HT; Yang LH; Wei Q; Liu Y; Zhang Y; Zhao Y; Dai SD; Miao Y; Yu JH; Zhang JY; Li G; Yuan XM; Wang EH
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):518-26. PubMed ID: 19735876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.